Drug-Drug Interactions Seen in Treatment for Hepatitis C

Module number
 
Date presented
December 4, 2018 
Duration
 
Audience
 
CE Credit
CEI 

On Tuesday, December 4th, Dr. Leah Burke of Yale School of Medicine/Yale-New Haven Hospital presented on: “Drug-Drug Interactions Seen in Treatment for Hepatitis C”

Learning Objectives:
1. Discuss recent developments in the treatment of hepatitis C virus (HCV).
2. Review clinically important effects, contraindications, and drug-drug interactions associated with medications used in the treatment of HCV.
3. Devise strategies for managing drug interactions with HCV therapies.

Presenter Bio:
Dr. Leah Burke is an Assistant Professor at Yale School of Medicine/Yale-New Haven Hospital and Adjunct Professor in the Division of Infectious Diseases at Weill Cornell Medical College.  She is an Investigator with the Cornell HIV Clinical Trials Unit, the national AIDS Clinical Trials Group (ACTG), and The Rockefeller University.  Her research focuses on clinical trials, aimed at improving the management of HIV and hepatitis C infections. Her interests involve HIV adherence, the use of monoclonal antibody therapy to treat or prevent HIV infection, and the efficacy of new treatment regimens for hepatitis C infection.

Disclosures: Dr. Burke received funding from Health 2.0 in conjunction with AdhereTech to study their wireless smart fill bottle technology for medication adherence.

Access the slides here